JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve the un-audited ....
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, February 10, 2026. The agenda includes considering and approving the un-audited financial results (both standalone and consolidated) for the quarter and nine months ended December 31, 2025. The company has also closed its trading window for insiders from January 1, 2026 until 48 hours after the results are announced. No financial figures have been disclosed in this intimation.
This is a routine regulatory filing ahead of the Q3 FY26 earnings announcement. Investors should wait for the actual results on February 10 to assess revenue, profitability, and margin trends. The trading window closure is standard practice and restricts insider trading during the results period.